Critical appraisal of the assessment of benefits and risks for foods, 'BRAFO Consensus Working Group'

Food and Chemical Toxicology

Volumn 55, Issue , 2013, Pages 659-675

  Boobis, Alan ^a   Chiodini, Alessandro ^b   Hoekstra, Jeljer ^c   Lagiou, Pagona ^d   Przyrembel, Hildegard ^e   Schlatter, Josef ^f   Schütte, Katrin ^h   Verhagen, Hans ^c,g   Watzl, Bernhard ⁱ  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b International Life Sciences Institute of Europe   (Belgium)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e not available   (Germany)

^f FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^g UNIVERSITY OF ULSTER   (United Kingdom)

^h PROCTER AND GAMBLE COMPANY   (United States)

ⁱ FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

Benefit risk assessment; BRAFO; Consensus; Risk management; Tiered approach

Indexed keywords

ACRYLAMIDE; ALPHA TOCOPHEROL; BENZO[A]PYRENE; BIOLOGICAL MARKER; CARBOHYDRATE; CHLORINE; DISACCHARIDASE; DRINKING WATER; FISH OIL; FOLIC ACID; LIPID; MONOUNSATURATED FATTY ACID; NITRATE; POLYCHLORINATED BIPHENYL; SATURATED FATTY ACID; SODIUM; SOYBEAN PROTEIN; SWEETENING AGENT;

ARTICLE; BREAD; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CEREAL; CONCEPTUAL FRAMEWORK; DATA ANALYSIS SOFTWARE; DECISION SUPPORT SYSTEM; DIET SUPPLEMENTATION; DIET THERAPY; DISABILITY ADJUSTED LIFE YEARS; ENVIRONMENTAL HEALTH; EVIDENCE BASED MEDICINE; FLUOR; FOOD; FOOD COMPOSITION; FOOD CONTAMINATION; FOOD CONTROL; FOOD INTAKE; FOOD PROCESSING; FOOD SAFETY; GENOTOXICITY; GOAL ATTAINMENT; HEALTH HAZARD; HUMAN; IN VITRO STUDY; LONG TERM EXPOSURE; MACRONUTRIENT; METHODOLOGY; MILK; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; PASTEURIZATION; POTATO; PUBLIC HEALTH; QUALITATIVE ANALYSIS; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SALMON; TOXICITY TESTING; TOXICODYNAMICS; TOXICOKINETICS; TOXICOLOGY;

ANIMALIA;

EID: 84875549901     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.10.028     Document Type: Article

References (97)

1. Aggett P.J., Antoine J.M., Asp N.G., Bellisle F., Contor L., Cummings J.H., Howlett J., Müller D.J., Persin C., Pijls L.T., Rechkemmer G., Tuijtelaars S., Verhagen H. PASSCLAIM: consensus on criteria. Eur. J. Nutr. 2005, 44(Suppl. 1):15-30.
2. Albers R., Antoine J.M., Bourdet-Sicard R., Calder P.C., Gleeson M., Lesourd B., Samartin S., Sanderson I.R., Van Loo J., Vas Dias F.W., Watzl B. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 2005, 94:452-481.
3. Bakker G.C., van Erk M.J., Pellis L., Wopereis S., Rubingh C.M., Cnubben N.H., Kooistra T., van Ommen B., Hendriks H.F. An antinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am. J. Clin. Nutr. 2010, 91:1044-1059.
4. Barendregt J.J., Veerman J.L. Categorical versus continuous risk factors and the calculation of potential impact fractions. J. Epidemiol. Commun. Health 2010, 64(3):209-212.
5. Barlow S.M., Greig J.B., Bridges J.W., Carere A., Carpy A.J., Galli C.L., Kleiner J., Knudsen I., Koëter H.B., Levy L.S., Madsen C., Mayer S., Narbonne J.F., Pfannkuch F., Prodanchuk M.G., Smith M.R., Steinberg P. Hazard identification by methods of animal-based toxicology. Food Chem. Toxicol. 2002, 40:145-191.
6. Barlow S., Renwick A.G., Kleiner J., Bridges J.W., Busk L., Dybing E., Edler L., Eisenbrand G., Fink-Gremmels J., Knaap A., Kroes R., Liem D., Müller D.J., Page S., Rolland V., Schlatter J., Tritscher A., Tueting W., Würtzen G. Risk assessment of substances that are both genotoxic and carcinogenic report of an international conference organized by EFSA and WHO with support of ILSI Europe. Food Chem. Toxicol. 2006, 44:1636-1650.
7. Benford D., Bolger P.M., Carthew P., Coulet M., DiNovi M., Leblanc J.C., Renwick A.G., Setzer W., Schlatter J., Smith B., Slob W., Williams G., Wildemann T. Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenic. Food Chem Toxicol. 2010, 48(Suppl. 1):S2-S24.
8. Bokkers B.G., Slob W. A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation. Toxicol. Sci. 2005, 85:1033-1040.
9. Boobis A.R. Risk assessment of dietary supplements. Novartis Found Symp. 2007, 282:3-25.
10. Boobis A.R., Cohen S.M., Dellarco V., McGregor D., Meek M.E., Vickers C., Willcocks D., Farland W. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 2006, 36:781-792.
11. Boobis A.R., Doe J.E., Heinrich-Hirsch B., Meek M.E., Munn S., Ruchirawat M., Schlatter J., Seed J., Vickers C. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 2008, 38:87-96.
12. Boobis A.R., Daston G.P., Preston R.J., Olin S.S. Application of key events analysis to chemical carcinogens and noncarcinogens. Crit. Rev. Food Sci. Nutr. 2009, 49:690-707.
13. Briggs D.J. A framework for integrated environmental health impact assessment of systemic risks. Environ. Health 2008, 7:61.
14. Chiba M., Ishii Y., Sugiyama Y. Prediction of hepatic clearance in human from in vitro data for successful drug development. AAPS J. 2009, 11:262-276.
15. Clewell R.A., Clewell H.J. Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regul. Toxicol. Pharmacol. 2008, 50:129-143.
16. Commission of the European Communities, 2000. White paper on food safety. Brussels, 12 January 2000. Available from: http://ec.europa.eu/dgs/health_consumer/library/pub/pub06_en.pdf.
17. Conolly R.B., Andersen M.E. Biologically based pharmacodynamic models: tools for toxicological research and risk assessment. Annu. Rev. Pharmacol. Toxicol. 1991, 31:503-523.
18. Conolly R.B., Kimbell J.S., Janszen D., Schlosser P.M., Kalisak D., Preston J., Miller F.J. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modelling of a combined rodent and human dataset. Toxicol. Sci. 2004, 82:279-296.
19. Crump K.S., Chen C., Chiu W.A., Louis T.A., Portier C.J., Subramaniam R.P., White P.D. What role for biologically based dose-response models in estimating low-dose risk?. Environ. Health Perspect. 2010, 118:585-588.
20. Daston G.P., Naciff J.M. Predicting developmental toxicity through toxicogenomics. Birth Defects Res. C Embryo Today 2010, 90:110-117.
21. Dodd K.W., Guenther P.M., Freedman L.S., Subar A.F., Kipnis V., Midthune D., Tooze J.A., Krebs-Smith S.M. Statistical methods for estimating usual intake of nutrients and foods: a review of the theory. J. Am. Diet. Assoc. 2006, 106:1640-1650.
22. Donato M.T., Lahoz A., Castell J.V., Gómez-Lechón M.J. Cell lines: a tool for in vitro drug metabolism studies. Curr. Drug Metab. 2008, 9:1-11.
23. Dorne J.L., Renwick A.G. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol. Sci. 2005, 86:20-26.
24. Dybing E., Doe J., Groten J., Kleiner J., O'Brien J., Renwick A.G., Schlatter J., Steinberg P., Tritscher A., Walker R., Younes M. Hazard characterisation of chemicals in food and diet. Dose response, mechanisms and extrapolation issues. Food Chem. Toxicol. 2002, 40:237-282.
25. Edler L., Poirier K., Dourson M., Kleiner J., Mileson B., Nordmann H., Renwick A., Slob W., Walton K., Würtzen G. Mathematical modelling and quantitative methods. Food Chem. Toxicol. 2002, 40:283-326.
26. EFSA Contam Statement on possible public health risks for infants and young children from the presence of nitrates in leafy vegetables. EFSA J. 2010, 8(12):1935. www.efsa.europa.eu/en/efsajournal/pub/689.htm. 10.2903/j.efsa.2010.1935.
27. EFSA NDA, 2011a. Nutrition and health claims. Avaliable from: Accessed 16/08/11. http://www.efsa.europa.eu/en/nda/ndaclaims.htm.
28. EFSA NDA General guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims. EFSA J. 2011, 9:2135-2159. http://www.efsa.europa.eu/en/efsajournal/doc/2135.pdf.
29. EFSA Scientific Committee Guidance on human health risk-benefit assessment of food. EFSA J. 2010, 8:1673-1713.
30. Elliott R., Pico C., Dommels Y., Wybranska I., Hesketh J., Keijer J. Nutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health. Br. J. Nutr 2007, 98:1095-1100.
31. El-Masri H.A. Experimental and mathematical modeling methods for the investigation of toxicological interactions. Toxicol. Appl. Pharmacol. 2007, 223:148-154.
32. E.U. Regulation, 2006. REGULATION (EC) No 1924/2006 Of The European Parliament and of the Council of 20 December 2006. Official Journal of the European Union. L 404/9.
33. Filipsson A.F., Sand S., Nilsson J., Victorin K. The benchmark dose method - review of available models, and recommendations for application in health risk assessment. Crit. Rev. Toxicol. 2003, 33:505-542.
34. Gaylor D.W. The use of Haber's law in standard setting and risk assessment. Toxicology 2000, 149:17-19.
35. Gómez-Lechón M.J., Castell J.V., Donato M.T. An update on metabolism studies using human hepatocytes in primary culture. Expert Opin. Drug Metab.Toxicol. 2008, 4:837-854.
36. Gundert-Remy U., Dahl S.G., Boobis A., Kremers P., Kopp-Schneider A., Oberemm A., Renwick A., Pelkonen O. Molecular approaches to the identification of biomarkers of exposure and effect - report of an expert meeting organized by COST Action B15. November 28, 2003. Toxicol. Lett. 2005, 156:227-240.
37. Guzelian P.S., Victoroff M.S., Halmes N.C., James R.C., Guzelian C.P. Evidence-based toxicology: a comprehensive framework for causation. Hum. Exp. Toxicol. 2005, 24:161-201.
38. Hart, A., Hoekstra, J., Owen, H., Kennedy, M., Zeilmaker, M., de Jong, N., Gunnlaugsdottir, H., 2013. Qalibra: a general model for food risk-benefit assessment that quantifies variability and uncertainty. Food Chem. Toxicol. http://dx.doi.org/10.1016/j.fct.2012.11.056.
39. Hattis D., Baird S., Goble R. A straw man proposal for a quantitative definition of the RfD. Drug Chem. Toxicol. 2002, 25:403-436.
40. Hays S.M., Aylward L.L. Using biomonitoring equivalents to interpret human biomonitoring data in a public health risk context. J. Appl. Toxicol. 2009, 29:275-288.
41. Hill B. The environment of disease: association or causation?. Proc. R. Soc. Med. 1965, 58:295-300.
42. Hoekstra J., Hart A., Boobis A., Claupein E., Cockburn A., Hunt A., Knudsen I., Richardson D., Schilter B., Schütte K., Torgerson P.R., Verhagen H., Watzl B., Chiodini A. BRAFO tiered approach for benefit-risk assessment of foods. Food Chem. Toxicol. 2010, 10.1016/j.fct.2010.05.04.
43. Hoekstra, J., Hart, A., Owen, H., Zeilmaker, M., Bokkers, B., Thorgilsson, B., Gunnlaugsdottir, H., 2012a. Fish, contaminants and human health: quantifying and weighing benefits and risks. Food Chem. Toxicol. 50, S684-S698.
44. Hoekstra J., Hart A., Owen H., Zeilmaker M., Bokkers B., Thorgilsson B., Gunnlaugsdottir H. Fish, contaminants and human health: quantifying and weighing benefits and risks. Food Chem. Toxicol. 2012, 10.1016/j.fct.2012.01.013.
45. Howlett J., Shortt C. PASSCLAIM - report of the Second Plenary Meeting: review of a wider set of interim criteria for the scientific substantiation of health claims. Eur. J. Nutr. 2004, 43(Suppl. 2):174-183.
46. Hulzebos E., Gunnarsdottir S., Rila J.P., Dang Z., Rorije E. An integrated assessment scheme for assessing the adequacy of (eco)toxicological data under REACH. Toxicol. Lett. 2010, 198:255-262.
47. Institute of Medicine Evaluation of biomarkers and surrogate endpoints in chronic disease 2010, The National Academies Press, Washington, D.C.
48. Jamei M., Dickinson G.L., Rostami-Hodjegan A. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: a tale of 'bottom-up' vs 'top-down' recognition of covariates. Drug Metab. Pharmacokinet. 2009, 24:53-75.
49. Jenab M., Slimani N., Bictash M., Ferrari P., Bingham S.A. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum. Genet. 2009, 125:507-525.
50. Julien E., Boobis A.R., Olin S.S. ILSI research foundation threshold working group. The key events dose-response framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds. Crit. Rev. Food Sci. Nutr. 2009, 49:682-689.
51. Kalogeras N., Odekerken-Schröder G., Pennings J.M.E., Gunnlaugsdόttir H., Holm F., Leino O., Luteijn J.M., Magnússon S.H., Pohjola M.V., Tijhuis M.J., Tuomisto J.T., Ueland Ø., White B.C., Verhagen H. State of the art in benefit-risk analysis: economics and marketing-finance. Food Chem. Toxicol. 2012, 50:56-66.
52. Kim D., Nylander-French L.A. Physiologically based toxicokinetic models and their application in human exposure and internal dose assessment. EXS 2009, 99:37-55.
53. Klimisch H.J., Andreae M., Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 1997, 25:1-5.
54. Kodell R.L., Gaylor D.W. Combining uncertainty factors in deriving human exposure levels of noncarcinogenic toxicants. Ann. NY Acad. Sci. 1999, 895:188-195.
55. Kroes R., Muller D., Lambe J., Kroes R., Müller D., Lambe J., Löwik M.R., van Klaveren J., Kleiner J., Massey R., Mayer S., Urieta I., Verger P., Visconti A. Assessment of intake from the diet. Food Chem. Toxicol. 2002, 40:327-385.
56. Laine R. Metabolic stability: main enzymes involved and best tools to assess it. Curr. Drug Metab. 2008, 9:921-927.
57. Li A.P. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem. Biol. Interact. 2007, 168:16-29.
58. Linkov I., Loney D., Cormier S., Satterstrom F.K., Bridges T. Weight-of-evidence evaluation in environmental assessment: review of qualitative and quantitative approaches. Sci. Total Environ. 2009, 407:5199-5205.
59. Luke N.S., Sams R., DeVito M.J., Conolly R.B., El-Masri H.A. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence. Toxicol. Sci. 2010, 115:253-266.
60. Luteijn J.M., White B.C., Gunnlaugsdóttir H., Holm F., Kalogeras N., Leino O., Magnússon S.H., Odekerken G., Pohjola M.V., Tijhuis M.J., Tuomisto J.T., Ueland Ø., McCarron P.A., Verhagen H. State of the art in benefit-risk analysis: medicines. Food Chem. Toxicol. 2012, 50:26-32.
61. Magnússon S.H., Gunnlaugsdóttir H., van Loveren H., Holm F., Kalogeras N., Leino O., Luteijn J.M., Odekerken G., Pohjola M.V., Tijhuis M.J., Tuomisto J.T., Ueland Ø., White B.C., Verhagen H. State of the art in benefit-risk analysis: food microbiology. Food Chem. Toxicol. 2012, 50:33-39.
62. Makris S.L., Thompson C.M., Euling S.Y., Selevan S.G., Sonawane B. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment. Birth Defects Res. B Dev. Reprod. Toxicol. 2008, 83:530-546.
63. Meek M.E. Categorical default uncertainty factors - interspecies variation and adequacy of database. Hum. Ecol. Risk Assess 2001, 7:157-163.
64. Miller F.J., Schlosser P.M., Janszen D.B. Haber's rule: a special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint. Toxicology 2000, 149:21-34.
65. O'Brien J., Renwick A.G., Constable A., Dybing E., Müller D.J., Schlatter J., Slob W., Tueting W., van Benthem J., Williams G.M., Wolfreys A. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal. Food Chem. Toxicol. 2006, 44:1613-1635.
66. Palou A., Pico C., Keijer J. Integration of risk and benefit analysis - the window of benefit as a new tool?. Crit. Rev. Food Sci. Nutr. 2009, 49:670-680.
67. Pelkonen O., Turpeinen M. In vitro-in vivo extrapolation of hepatic clearance. Biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 2007, 37:1066-1089.
68. Pohjola M.V., Leino O., Kollanus V., Tuomisto J.T., Gunnlaugsdóttir H., Holm F., Kalogeras N., Luteijn J.M., Magnússon S.H., Odekerken G., Tijhuis M.J., Ueland Ø., White B.C., Verhagen H. State of the art in benefit-risk analysis: environmental health. Food Chem. Toxicol. 2012, 50:40-55.
69. Pratt I., Barlow S., Kleiner J., Larsen J.C. The influence of thresholds on the risk assessment of carcinogens in food. Mutat. Res. 2009, 678:113-117.
70. Preston J.R., Williams G.M. DNA-reactive carcinogens: mode of action and human cancer hazard. Crit. Rev. Toxicol. 2005, 35:673-683.
71. Renwick A.G., Barlow S.M., Hertz-Picciotto I., Boobis A.R., Dybing E., Edler L., Eisenbrand G., Greig J.B., Kleiner J., Lambe J., Müller D.J., Smith M.R., Tritscher A., Tuijtelaars S., van den Brandt P.A., Walker R., Kroes R. Risk characterisation of chemicals in food and diet. Food Chem. Toxicol. 2003, 41:1211-1271.
72. Sand S., Victorin K., Filipsson A.F. The current state of knowledge on the use of the benchmark dose concept in risk assessment. J. Appl. Toxicol. 2008, 28:405-421.
73. Schneider K., Schwarz M., Burkholder I., Kopp-Schneider A., Edler L., Kinsner-Ovaskainen A., Hartung T., Hoffmann S. " ToxRTool" , a new tool to assess the reliability of toxicological data. Toxicol. Lett. 2009, 189:138-144.
74. Schünemann, H.J., Oxman, A.D., Vist, G.E., Higgins, J.P.T., Deeks, J.J., Glasziou, P., Guyatt, G.H., 2008. Interpreting results and drawing conclusions. In: Higgins, J.P.T., Green, S., (Eds.), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1, Chapter 12. The Cochrane Collaboration, 2008. Available from: http://www.cochrane-handbook.org.
75. Schütte K., Boeing H., Hart A., Heeschen W., Reimerdes E.H., Santare D., Skog K., Chiodini A. Application of the BRAFO tiered approach for benefit-risk assessment to case studies on heat processing contaminants. Food Chem. Toxicol. 2012, 50:S724-S735.
76. Seed J., Carney E.W., Corley R.A., Crofton K.M., DeSesso J.M., Foster P.M., Kavlock R., Kimmel G., Klaunig J., Meek M.E., Preston R.J., Slikker W., Tabacova S., Williams G.M., Wiltse J., Zoeller R.T., Fenner-Crisp P., Patton D.E. Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Drug Chem. Toxicol. 2005, 35:664-672.
77. Slikker W., Andersen M.E., Bogdanffy M.S., Bus J.S., Cohen S.D., Conolly R.B., David R.M., Doerrer N.G., Dorman D.C., Gaylor D.W., Hattis D., Rogers J.M., Woodrow-Setzer R., Swenberg J.A., Wallace K. Dose-dependent transitions in mechanisms of toxicity. Toxicol. Appl. Pharmacol. 2004, 201:203-225.
78. Slob W., Pieters M.N. A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological studies: general framework. Risk Anal. 1998, 18:787-798.
79. Solecki R., Davies L., Dellarco V., Dewhurst I., Raaij M., Tritscher A. Guidance on setting of acute reference dose (ARfD) for pesticides. Food Chem. Toxicol. 2005, 43:1569-1593.
80. Sonich-Mullin C., Fielder R., Wiltse J., Baetcke K., Dempsey J., Fenner-Crisp P., Grant D., Hartley M., Knaap A., Kroese D., Mangelsdorf I., Meek E., Rice J.M., Younes M. International programme on chemical safety. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 2001, 34:146-152.
81. Souverein O.W., Dekkers A.L., Geelen A., Haubrock J., de Vries J.H., Ocké M.C., Harttig U., Boeing H., van 't Veer P. Comparing four methods to estimate usual intake distributions. Eur. J. Clin. Nutr. 2011, 65(Suppl. 1):S92-S101.
82. Subramaniam R.P., White P., Cogliano V.J. Comparison of cancer slope factors using different statistical approaches. Risk Anal. 2006, 26:825-830.
83. Tijhuis M.J., de Jong N., Pohjola M.V., Gunnlaugsdóttir H., Hendriksen M., Hoekstra J., Holm F., Kalogeras N., Leino O., van Leeuwen F.X., Luteijn J.M., Magnússon S.H., Odekerken G., Rompelberg C., Tuomisto J.T., Ueland O., White B.C., Verhagen H. State of the art in benefit-risk analysis: food and nutrition. Food Chem. Toxicol. 2012, 50:5-25.
84. Tijhuis M.J., Pohjola M.V., Gunnlaugsdóttir H., Kalogeras N., Leino O., Luteijn J.M., Magnússon S.H., Odekerken-Schröder G., Poto M., Tuomisto J.T., Ueland O., White B.C., Holm F., Verhagen H. Looking beyond borders: integrating best practices in benefit-risk analysis into the field of food and nutrition. Food Chem. Toxicol. 2012, 50:77-93.
85. Ueland Ø., Gunnlaugsdottir H., Holm F., Kalogeras N., Leino O., Luteijn J.M., Magnússon S.H., Odekerken G., Pohjola M.V., Tijhuis M.J., Tuomisto J.T., White B.C., Verhagen H. State of the art in benefit-risk analysis: consumer perception. Food Chem. Toxicol. 2012, 50:67-76.
86. Valcke M., Krishnan K. Evaluation of the impact of the exposure route on the human kinetic adjustment factor. Regul. Toxicol. Pharmacol. 2011, 59:258-269.
87. Verhagen H., Vos E., Francl S., Heinonen M., van Loveren H. Status of nutrition and health claims in Europe. Arch. Biochem. Biophys. 2010, 510:6-15.
88. Verhagen H., Andersen R., Antoine J.M., Finglas P., Hoekstra J., Kardinaal A., Nordmann H., Pekcan G., Pentieva K., Sanders T.A., van den Berg H., van Kranen H., Chiodini A. Application of the BRAFO tiered approach for benefit-risk assessment to case studies on dietary interventions. Food Chem. Toxicol. 2012, 50:S710-S723.
89. Verhagen H., Tijhuis M.J., Gunnlaugsdόttir H., Kalogeras N., Leino O., Luteijn J.M., Magnússon S.H., Odekerken G., Pohjola M.V., Tuomisto J.T., Ueland Ø., White B.C., Holm F. State of the art in benefit-risk analysis: introduction. Food Chem. Toxicol. 2012, 50:2-4.
90. Vermeir M., Annaert P., Mamidi R.N., Roymans D., Meuldermans W., Mannens G. Cell-based models to study hepatic drug metabolism and enzyme induction in humans. Expert Opin. Drug Metab.Toxicol. 2005, 1:75-90.
91. Vermeire T., Stevenson H., Peiters M.N., Rennen M., Slob W., Hakkert B.C. Assessment factors for human health risk assessment: a discussion paper. Drug Chem. Toxicol. 1999, 29:439-490.
92. Vlaanderen J., Moore L.E., Smith M.T., Lan Q., Zhang L., Skibola C.F., Rothman N., Vermeulen R. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup. Environ. Med. 2010, 67:136-143.
93. Watzl B., Gelencsér E., Hoekstra J., Kulling S., Lydeking-Olsen E., Rowland I., Schilter B., van Klaveren J., Chiodini A. Application of the BRAFO-tiered approach for benefit-risk assessment to case studies on natural foods. Food Chem. Toxicol. 2012, 50:S699-S709.
94. WHO, 2003. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. WHO Technical Report Series 916. World Health Organization, Geneva, Switzerland. Available from: (accessed 06/04/2011). http://www.fao.org/DOCREP/005/AC911E/AC911E00.HTM.
95. WHO, 2005. Chemical-specific adjustment factors for interspecies differences and human variability: Guidance document for use of data in dose/concentration-response assessment, WHO, Geneva. Available from: (accessed 30/10/10). http://www.inchem.org/documents/harmproj/harmproj/harmproj2.pdf.
96. WHO, 2009. Principles and methods for the risk assessment of chemicals in food. EHC 240, ISBN 978 92 4 157240 8, WHO, Geneva. Available online at http://www.who.int/ipcs/food/principles/en/index1.html.
97. Zhang Q., Bhattacharya S., Andersen M.E., Conolly R.B. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing. J. Toxicol. Environ. Health B Crit. Rev. 2010, 13:253-276.